176 related articles for article (PubMed ID: 18004603)
21. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.
Jasmin SB; Pearson V; Lalonde D; Domenger D; Théroux L; Poirier J
Brain Res; 2014 May; 1562():39-51. PubMed ID: 24661912
[TBL] [Abstract][Full Text] [Related]
23. Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice.
Tang W; Ma Y; Jia L; Ioannou YA; Davies JP; Yu L
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):448-54. PubMed ID: 18187667
[TBL] [Abstract][Full Text] [Related]
24. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.
Kaneko E; Matsuda M; Yamada Y; Tachibana Y; Shimomura I; Makishima M
J Biol Chem; 2003 Sep; 278(38):36091-8. PubMed ID: 12847102
[TBL] [Abstract][Full Text] [Related]
25. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
[TBL] [Abstract][Full Text] [Related]
26. A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux.
Sparrow CP; Baffic J; Lam MH; Lund EG; Adams AD; Fu X; Hayes N; Jones AB; Macnaul KL; Ondeyka J; Singh S; Wang J; Zhou G; Moller DE; Wright SD; Menke JG
J Biol Chem; 2002 Mar; 277(12):10021-7. PubMed ID: 11790770
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological activation of LXR in utero directly influences ABC transporter expression and function in mice but does not affect adult cholesterol metabolism.
van Straten EM; Huijkman NC; Baller JF; Kuipers F; Plösch T
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1341-8. PubMed ID: 18840761
[TBL] [Abstract][Full Text] [Related]
28. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
Breevoort SR; Angdisen J; Schulman IG
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
[TBL] [Abstract][Full Text] [Related]
29. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.
Singaraja RR; Bocher V; James ER; Clee SM; Zhang LH; Leavitt BR; Tan B; Brooks-Wilson A; Kwok A; Bissada N; Yang YZ; Liu G; Tafuri SR; Fievet C; Wellington CL; Staels B; Hayden MR
J Biol Chem; 2001 Sep; 276(36):33969-79. PubMed ID: 11423537
[TBL] [Abstract][Full Text] [Related]
30. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
[TBL] [Abstract][Full Text] [Related]
31. TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2.
Field FJ; Watt K; Mathur SN
J Lipid Res; 2010 Jun; 51(6):1407-15. PubMed ID: 20103810
[TBL] [Abstract][Full Text] [Related]
32. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression.
Ou X; Dai X; Long Z; Tang Y; Cao D; Hao X; Hu Y; Li X; Tang C
Sci China C Life Sci; 2008 May; 51(5):418-29. PubMed ID: 18785587
[TBL] [Abstract][Full Text] [Related]
33. Liver X receptors regulate cholesterol homeostasis in oligodendrocytes.
Nelissen K; Mulder M; Smets I; Timmermans S; Smeets K; Ameloot M; Hendriks JJ
J Neurosci Res; 2012 Jan; 90(1):60-71. PubMed ID: 21972082
[TBL] [Abstract][Full Text] [Related]
34. TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.
Zhu C; Di D; Zhang X; Luo G; Wang Z; Wei J; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2011 Nov; 10():199. PubMed ID: 22054074
[TBL] [Abstract][Full Text] [Related]
35. Non-steroidal LXR agonists; an emerging therapeutic strategy for the treatment of atherosclerosis.
Bennett DJ; Cooke AJ; Edwards AS
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):21-46. PubMed ID: 18221072
[TBL] [Abstract][Full Text] [Related]
36. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice.
Knight BL; Patel DD; Humphreys SM; Wiggins D; Gibbons GF
J Lipid Res; 2003 Nov; 44(11):2049-58. PubMed ID: 12897186
[TBL] [Abstract][Full Text] [Related]
38. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.
Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F
J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210
[TBL] [Abstract][Full Text] [Related]
39. Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages.
Ku CS; Park Y; Coleman SL; Lee J
J Nutr Biochem; 2012 Oct; 23(10):1271-6. PubMed ID: 22209005
[TBL] [Abstract][Full Text] [Related]
40. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
